Júlia C.F. Quintanilha

850 total citations
63 papers, 520 citations indexed

About

Júlia C.F. Quintanilha is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Júlia C.F. Quintanilha has authored 63 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Oncology, 29 papers in Cancer Research and 21 papers in Pathology and Forensic Medicine. Recurrent topics in Júlia C.F. Quintanilha's work include Cancer Genomics and Diagnostics (20 papers), Colorectal Cancer Treatments and Studies (14 papers) and Chemotherapy-induced organ toxicity mitigation (11 papers). Júlia C.F. Quintanilha is often cited by papers focused on Cancer Genomics and Diagnostics (20 papers), Colorectal Cancer Treatments and Studies (14 papers) and Chemotherapy-induced organ toxicity mitigation (11 papers). Júlia C.F. Quintanilha collaborates with scholars based in United States, Brazil and Chile. Júlia C.F. Quintanilha's co-authors include Patrícia Moriel, Marília Berlofa Visacri, Ryon P. Graf, Luis A. Salazar, Geoffrey R. Oxnard, Carmen Sílvia Passos Lima, Gerald Li, Tomás Zambrano, Jeffrey S. Ross and Douglas I. Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Júlia C.F. Quintanilha

58 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Júlia C.F. Quintanilha United States 13 172 159 152 142 103 63 520
Massimo Madonia Italy 16 129 0.8× 213 1.3× 130 0.9× 72 0.5× 143 1.4× 50 825
Firas Baidoun United States 6 311 1.8× 246 1.5× 170 1.1× 105 0.7× 147 1.4× 28 722
Maurizio Capuozzo Italy 13 165 1.0× 147 0.9× 60 0.4× 35 0.2× 56 0.5× 53 549
Kannan Thanikachalam United States 5 213 1.2× 241 1.5× 152 1.0× 65 0.5× 77 0.7× 10 562
Francesca Montalto Italy 10 111 0.6× 254 1.6× 113 0.7× 39 0.3× 62 0.6× 15 569
Kensuke Mitsunari Japan 13 103 0.6× 289 1.8× 112 0.7× 47 0.3× 137 1.3× 68 677
Hisakazu Komori Japan 14 115 0.7× 243 1.5× 92 0.6× 32 0.2× 31 0.3× 26 544
Jianrong Guo China 13 93 0.5× 202 1.3× 98 0.6× 48 0.3× 88 0.9× 23 496

Countries citing papers authored by Júlia C.F. Quintanilha

Since Specialization
Citations

This map shows the geographic impact of Júlia C.F. Quintanilha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Júlia C.F. Quintanilha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Júlia C.F. Quintanilha more than expected).

Fields of papers citing papers by Júlia C.F. Quintanilha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Júlia C.F. Quintanilha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Júlia C.F. Quintanilha. The network helps show where Júlia C.F. Quintanilha may publish in the future.

Co-authorship network of co-authors of Júlia C.F. Quintanilha

This figure shows the co-authorship network connecting the top 25 collaborators of Júlia C.F. Quintanilha. A scholar is included among the top collaborators of Júlia C.F. Quintanilha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Júlia C.F. Quintanilha. Júlia C.F. Quintanilha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schulze, Markus, et al.. (2025). Real‐world genomic landscape of colon and rectal cancer. FEBS Open Bio. 15(4). 674–685. 1 indexed citations
2.
Slomovitz, Brian M., Natalie Danziger, Júlia C.F. Quintanilha, et al.. (2025). Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancer. International Journal of Gynecological Cancer. 35(10). 102107–102107. 1 indexed citations
3.
4.
5.
Richardson, Debra L., Júlia C.F. Quintanilha, Natalie Danziger, et al.. (2024). Effectiveness of PARP Inhibitor Maintenance Therapy in Ovarian Cancer by BRCA1/2 and a Scar-Based HRD Signature in Real-World Practice. Clinical Cancer Research. 30(20). 4644–4653. 5 indexed citations
6.
Vogel, Arndt, Karthikeyan Murugesan, Júlia C.F. Quintanilha, et al.. (2024). Association of RNF43 Genetic Alterations With BRAFV600E and MSIhigh in Colorectal Cancer. JCO Precision Oncology. 8(8). e2300411–e2300411. 2 indexed citations
7.
Quintanilha, Júlia C.F., William Kevin Kelly, & Federico Innocenti. (2024). Contribution of plasma levels of VEGF-A and angiopoietin-2 in addition to a genetic variant in KCNAB1 to predict the risk of bevacizumab-induced hypertension. The Pharmacogenomics Journal. 24(4). 22–22. 1 indexed citations
8.
Parseghian, Christine M., Júlia C.F. Quintanilha, Alexa B. Schrock, et al.. (2024). Novel potential mechanisms of acquired resistance to anti-EGFR monoclonal antibody (mAb) therapy detected in liquid biopsies (LBx) from patients (pts) with advanced colorectal cancer (CRC).. Journal of Clinical Oncology. 42(3_suppl). 199–199.
9.
Bhave, Manali, Júlia C.F. Quintanilha, Hanna Tukachinsky, et al.. (2024). Comprehensive genomic profiling of ESR1, PIK3CA, AKT1, and PTEN in HR(+)HER2(−) metastatic breast cancer: prevalence along treatment course and predictive value for endocrine therapy resistance in real-world practice. Breast Cancer Research and Treatment. 207(3). 599–609. 11 indexed citations
10.
11.
Quintanilha, Júlia C.F., Ryon P. Graf, Virginia Fisher, et al.. (2023). Comparative Effectiveness of Immune Checkpoint Inhibitors vs Chemotherapy in Patients With Metastatic Colorectal Cancer With Measures of Microsatellite Instability, Mismatch Repair, or Tumor Mutational Burden. JAMA Network Open. 6(1). e2252244–e2252244. 26 indexed citations
12.
Quintanilha, Júlia C.F., Ryon P. Graf, Gerald Li, et al.. (2023). Tumor Mutational Burden in Real-World Patients With Pancreatic Cancer: Genomic Alterations and Predictive Value for Immune Checkpoint Inhibitor Effectiveness. JCO Precision Oncology. 7(7). 26–27. 31 indexed citations
13.
Gandara, David R., Neeraj Agarwal, Shilpa Gupta, et al.. (2023). Tumor mutational burden (TMB) measurement from an FDA-approved assay and real-world overall survival (rwOS) on single-agent immune checkpoint inhibitors (ICI) in over 8,000 patients across 24 cancer types.. Journal of Clinical Oncology. 41(16_suppl). 2503–2503. 10 indexed citations
14.
Quintanilha, Júlia C.F., et al.. (2023). miR-6805-5p as a biomarker of cisplatin-induced nephrotoxicity in patients with head and neck cancer. Frontiers in Pharmacology. 14. 1275238–1275238. 4 indexed citations
15.
Visacri, Marília Berlofa, Júlia C.F. Quintanilha, Maurício Wesley Perroud, et al.. (2022). Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary results. Molecular Biology Reports. 49(7). 6931–6943. 20 indexed citations
16.
Quintanilha, Júlia C.F., Alessandro Racioppi, Jin Wang, et al.. (2021). PIK3R5 genetic predictors of hypertension induced by VEGF-pathway inhibitors. The Pharmacogenomics Journal. 22(1). 82–88. 6 indexed citations
17.
Mazetto, Bruna de Moraes, et al.. (2021). Self-perceived quality of life of primary antiphospholipid syndrome patients using vitamin K antagonist. Lupus. 30(5). 707–714. 2 indexed citations
18.
Quintanilha, Júlia C.F., et al.. (2017). Cisplatin-induced human peripheral blood mononuclear cells’ oxidative stress and nephrotoxicity in head and neck cancer patients: the influence of hydrogen peroxide. Molecular and Cellular Biochemistry. 440(1-2). 139–145. 17 indexed citations
19.
Nogueira, Guilherme, Marília Berlofa Visacri, Júlia C.F. Quintanilha, et al.. (2017). GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.‐1339A>G Polymorphisms and Severity of Vomiting in Head and Neck Cancer Patients treated with Cisplatin Chemoradiation. Basic & Clinical Pharmacology & Toxicology. 121(6). 520–525. 12 indexed citations
20.
Visacri, Marília Berlofa, et al.. (2017). Adverse drug reactions and kinetics of cisplatin excretion in urine of patients undergoing cisplatin chemotherapy and radiotherapy for head and neck cancer: a prospective study. DARU Journal of Pharmaceutical Sciences. 25(1). 12–12. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimo Madonia Breakdown of academic impact, for papers by Firas Baidoun Breakdown of academic impact, for papers by Maurizio Capuozzo Breakdown of academic impact, for papers by Kannan Thanikachalam Breakdown of academic impact, for papers by Francesca Montalto Breakdown of academic impact, for papers by Kensuke Mitsunari Breakdown of academic impact, for papers by Hisakazu Komori Breakdown of academic impact, for papers by Jianrong Guo
Rankless by CCL
2026